Securities

  • June 10, 2026

    Ex-TD Bank Teller Gets 2 Years For Laundering Drug Cash

    A New Jersey federal judge sentenced a former TD Bank NA teller on Wednesday to two years in federal prison for accepting bribes and helping launder millions of dollars in drug proceeds through a scheme that transferred illicit money from the U.S. to Colombia.

  • June 10, 2026

    Elliott, Stronghold Clash Over Oil And Gas Asset Wind-Down

    Elliott Investment Management LP and Stronghold Resource Partners urged the Delaware Supreme Court on Tuesday to adopt competing readings of a settlement agreement governing the wind-down of an oil and gas investment fund, with each side saying the contract's language supports a different path for liquidating the fund's remaining holdings.

  • June 10, 2026

    Molina Says Its Warnings Doom Suit Over Guidance Cuts

    Health insurance provider Molina Healthcare and two of its executives urged a California federal court to dismiss a shareholder suit accusing them of misleading investors about medical costs and internal controls before repeatedly slashing the company's 2025 earnings guidance, arguing that the nature of its business makes costs unpredictable.

  • June 10, 2026

    CFTC Plans To OK Sports Betting On Prediction Markets

    The U.S. Commodity Futures Trading Commission proposed a rule Wednesday that could govern the way the agency oversees the prediction markets, indicating that trading platforms will be allowed to continue accepting bets on the outcome of professional and college-level sports.

  • June 10, 2026

    Warren Asks SEC To Delay SpaceX IPO Over 'Troubling' Risks

    U.S. Sen. Elizabeth Warren called on the U.S. Securities and Exchange Commission to delay SpaceX's anticipated $75 billion initial public offering until steps are taken to protect investors and market integrity, expressing concerns that the company's books contain "troubling gaps," and the IPO poses "unique and precedent-setting" risk.

  • June 10, 2026

    Acadia Pharma Must Face Investors' Drug Approval Claims

    Acadia Pharmaceuticals must face investors' class action claims it misstated the likelihood that it would get regulatory approval to market its psychosis drug pimavanserin for expanded use, a California federal judge determined, finding a key question about a regulator's directions should be decided by a jury.

  • June 10, 2026

    Zillow-Redfin Noncompete Deal Sank Stock, Investor Claims

    A proposed class of Zillow Group Inc. shareholders accused the property listings company of making an anticompetitive noncompete agreement with rival Redfin Corp., which caused the federal government to file an antitrust suit and Zillow's common stock value to drop.

  • June 09, 2026

    Kalshi To Start Requiring Employer Info For Certain Markets

    Prediction market platform Kalshi Inc. announced on Tuesday that it will start requiring users to verify their employer before they can trade on certain markets, and will further implement features allowing users to directly report suspicious trading activity.

  • June 09, 2026

    NY Floats Rule To Align Its Stablecoin Regs With Genius Act

    New York's Department of Financial Services on Tuesday proposed regulations to ensure its existing stablecoin framework aligns with the U.S. Treasury Department's coming requirements for state regimes under the federal law governing stable-value tokens.

  • June 09, 2026

    FDIC's Hill Eyes Resolution Planning, Assessment Changes

    Federal Deposit Insurance Corp. Chairman Travis Hill said Tuesday that his agency will seek to dial back its living-will requirements for large banks and recalibrate how it charges for deposit insurance, part of a broader push to rethink the agency's approach to handling bank failures.

  • June 09, 2026

    DC Circ. Says PCAOB Challenger Must Reveal His Name

    The D.C. Circuit Tuesday backed a D.C. federal court's holding that a man anonymously challenging the constitutionality of the Public Company Accounting Oversight Board should be required to identify himself.

  • June 09, 2026

    OCC Says Fidelity's Crypto Bank Doesn't Need State Licenses

    The Office of the Comptroller of the Currency on Tuesday told Fidelity's crypto-focused trust bank that it can operate nationwide without state money transmitter licenses, taking the firm's side in a licensing dispute with Iowa following its conversion to a national trust charter.

  • June 09, 2026

    SEC Flags Improper Investment Adviser Conflict Disclosures

    U.S. Securities and Exchange Commission examiners Tuesday urged investment advisers to ensure they are properly disclosing economic conflicts of interest to clients, warning that exams staff have identified undisclosed conflicts and incomplete or misleading disclosures.

  • June 09, 2026

    Investor Says Vikasa Still Owes $1.15M For Settlement

    A California investor has sued in the Delaware Chancery Court seeking to enforce a settlement with investment firm Vikasa Capital Inc., claiming the company paid only a fraction of the $1.25 million it agreed to pay to resolve claims that it fraudulently induced a $5 million investment through misrepresentations and doctored corporate records.

  • June 09, 2026

    Columbia Bank Must Face Suit Over $230M Ponzi Scheme

    A Washington federal judge on Tuesday preserved a bankruptcy trust's lawsuit against Columbia Bank, finding that the trust adequately alleged the bank helped a real estate business' former operators run a $230 million Ponzi scheme.

  • June 09, 2026

    PCAOB Eyes Rollbacks Of Biden-Era Quality Control Rules

    The Public Company Accounting Oversight Board on Tuesday put forth a proposal that would rescind some quality control standards adopted in 2024, including a requirement that the largest public company auditors employ an outside expert to evaluate the effectiveness of their quality control systems.

  • June 09, 2026

    BioTech Co. Hit Investor Suit Over Cancer Test Trial Miss

    Biotechnology company Grail Inc. was hit with a proposed investor class action alleging that it misled investors about the likelihood its cancer screening blood test would demonstrate effectiveness in a clinical trial, which the public learned in February was unsuccessful.

  • June 09, 2026

    SPAR Board Hit With $22M Insider Control Suit In Chancery

    A SPAR Group Inc. stockholder has filed a derivative lawsuit in the Delaware Chancery Court accusing several current and former directors and officers of orchestrating a yearslong scheme to maintain control of the company's board, enrich insiders and approve conflicted transactions that allegedly cost the company $22 million.

  • June 01, 2026

    Cere Founder Says Sale Pact Bars $13M Crypto Fraud Suit

    Cere Network's co-founder and others targeted in a $13 million suit over a purported cryptocurrency fraud scheme involving the decentralized data cloud platform have asked a California federal judge to send the dispute to arbitration in San Francisco.

  • June 09, 2026

    Cognizant Settles Suit Over 401(k) Investment Management

    Cognizant Technology Solutions and former employees who claimed the information technology company saddled its 401(k) plan with poor investment options and high fees told a New Jersey federal judge that they have agreed to settle their dispute.

  • June 09, 2026

    Apollo SLC Opposes Bid To Oust Judge In $570M Payout Suit

    A special litigation committee of Apollo Global Management Inc.'s board is opposing a bid to disqualify a Delaware vice chancellor from presiding over litigation regarding a $570 million payout to company insiders due to a possible conflict because she previously was an attorney at Skadden Arps Slate Meagher & Flom LLP, saying there are no grounds for disqualification.

  • June 09, 2026

    Blue Owl Tech Credit Adviser Hit With Excessive Fee Lawsuit

    An adviser subsidiary of private credit giant Blue Owl Capital Corp. faces shareholder derivative claims that it improperly inflated the assets of a technology-focused fund to boost its fees even as those fee increases outpaced the fund's growth.

  • June 09, 2026

    The Law360 400: A Look At The Top 100 Firms

    The race to build the legal industry's largest law firm accelerated in 2025, with major firms leaning on mergers, lateral hiring and strategic expansion to climb the ranks of the Law360 400.

  • June 09, 2026

    QXO Stockholder Sues Over TopBuild Deal Disclosures

    A QXO Inc. stockholder has filed a proposed class action in the Delaware Chancery Court seeking to block a shareholder vote tied to the company's planned $17 billion acquisition of TopBuild Corp., alleging that investors were not given enough information to make an informed decision on the deal.

  • June 08, 2026

    OpenAI Joins Anthropic In Confidentially Filing IPO Plans

    OpenAI said Monday that it had confidentially submitted a proposed initial public offering to the U.S. Securities and Exchange Commission, an announcement that comes a week after artificial intelligence rival Anthropic said it had done the same.

Expert Analysis

  • One Idea To Fix The SEC's Risk Factor Disclosure Rules

    Author Photo

    U.S. Securities and Exchange Commission Chairman Paul Atkins recently invited the industry to suggest ways to reform the current risk factor disclosure framework, and amending Rule 10b-5 is one potential option to consider, say attorneys at A&O Shearman.

  • Agentic AI Use May Trigger Existing Consumer Finance Laws

    Author Photo

    As artificial intelligence agents interact more and more with payment systems, financial institutions should be cognizant of how existing consumer protection laws like the Equal Credit Opportunity Act apply when transactions are executed by automated systems rather than individuals, noting authorization and liability gaps, say attorneys at Sheppard.

  • 3 Policy Lines To Revisit After Justices Nix Emergency Tariffs

    Author Photo

    The U.S. Supreme Court's invalidation of President Donald Trump's emergency-based tariffs could expose businesses to allegations of misrepresenting tariff effects and raise the prospect of consumer actions seeking refunds — underscoring the need for policyholders to potentially reposition their insurance portfolios, say attorneys at Reed Smith.

  • SEC Guidance Further Solidifies Status Of Tokenized Assets

    Author Photo

    The U.S. Securities and Exchange Commission recently released a statement that tokenized securities are securities governed by traditional securities laws, representing continued regulatory clarity and the development of expanded technical standards and risk management guidelines that can only improve the long-term viability of financial markets, say attorneys at Barnes & Thornburg.

  • 5 Tips For Navigating Your Firm's All-Attorney Summit

    Excerpt from Practical Guidance
    Author Photo

    Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.

  • CFTC's No-Action Relief Fuels Energy Market Competition

    Author Photo

    The U.S. Commodity Futures Trading Commission recently launched a pilot program aimed at expanding access to energy markets, reflecting a shift toward supporting robust derivatives markets that balance regulatory safeguards with the needs of commodity end users, say attorneys at Moore & Van Allen.

  • Opinion

    Clarity Act Would Clear Welcome Pathways For Blockchain

    Author Photo

    The framework proposed under the Senate Banking Committee's version of the Clarity Act creates reasonable compliance obligations and meaningful token-distribution opportunities that would open the door for more U.S.-based blockchain projects, without the heightened risk of securities litigation and regulatory enforcement, says Karen Ubell at Goodwin.

  • 6 Noteworthy Changes From SEC Enforcement Manual Update

    Author Photo

    Recent updates to the U.S. Securities and Exchange Commission’s enforcement manual represent a commitment to transparency and fair process, with the signature change being a requirement that staff make certain probative evidence available during the Wells process, say attorneys at Debevoise.

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • What Texas Anti-Boycott Ruling Means For ESG Landscape

    Author Photo

    A Texas federal court's recent ruling in American Sustainable Business Council v. Hegar that Texas' anti-ESG law is unconstitutional on First Amendment grounds will likely embolden legal challenges to similar laws in other states that have adopted fossil fuel boycott statutes, say attorneys at ArentFox Schiff.

  • How To Wield The Clarity Act As A Litigation Defense Tool

    Author Photo

    The Clarity Act is being discussed as a future compliance statute, but for litigators it can be used as a present-day defense tool to strengthen fair‑notice framing, argue for forward‑looking remedies rather than punitive ones and reprice settlement leverage as statutory clarity approaches, say attorneys at Baker McKenzie.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • How DExit, Mandatory Arbitration Could Alter IPO Outlook

    Author Photo

    As companies continue to leave Delaware and the U.S. Securities and Exchange Commission begins allowing companies to implement mandatory arbitration provisions, these developments could have a major impact on the initial public offering, securities class action, and directors and officers insurance landscapes, says Walker Newell at Arthur J. Gallagher & Co.

  • Why Prediction Market Regulation Is At Major Inflection Point

    Author Photo

    As prediction markets experience tremendous growth and rapid mainstream adoption, regulators have begun to exercise enforcement authority to ensure market integrity and protect participants, though forthcoming guidance will shed light on how aggressively the agencies will police the fast-changing landscape, say attorneys at Latham.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Securities archive.